Covered recipient · General Payments record
PIPPA R SOILEAU
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2023
$1,380.21
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $373.86 | 15 |
| Education | $48.84 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $214.11 | 7 |
| ITI, Inc. | $72.00 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.52 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $36.63 | 2 |
| IRONSHORE PHARMACEUTICALS INC. | $35.82 | 2 |
| Teva Pharmaceuticals USA, Inc. | $20.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.90 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009874045 | CMS |
| ABBVIE INC. | $125.00 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009874049 | CMS |
| ABBVIE INC. | $11.11 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009874053 | CMS |
| ABBVIE INC. | $11.74 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009874057 | CMS |
| ABBVIE INC. | $13.36 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009874059 | CMS |
| ABBVIE INC. | $19.40 | 08/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009874063 | CMS |
| ABBVIE INC. | $20.60 | 09/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009874067 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $17.41 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034549549 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $19.22 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034549555 | CMS |
| Ironshore Pharmaceuticals Inc. | $21.16 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060478763 | CMS |
| Ironshore Pharmaceuticals Inc. | $14.66 | 07/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060478613 | CMS |
| ITI, Inc. | $23.16 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1041142873 | CMS |
| ITI, Inc. | $48.84 | 04/11/2023 | Education | Undisputed | 01/23/2026 | 1041142879 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.00 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056024195 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.52 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056024197 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.62 | 07/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056980889 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.